✨
AI Summary
- Doctors Price and Hart discuss medicine's evolution with patient access to new treatments and information.
- They cover unapproved peptides, GLP-1 drugs, personalized care, and regulatory challenges.
- The conversation touches on Canada's opioid crisis, decriminalization, and fentanyl contamination.
Guests on This Episode
IP
Ira Price
1 podcast appearance